Olimel N9

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non‑essential amino acids presented as a powder for oral use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N9 provides amino acid supplementation that supports several clinical situations where protein intake is compromised. - Post‑operative recovery: helps maintain nitrogen balance and tissue repair. - Chronic kidney disease management: assists in managing amino‑acid loss during dialysis. - Severe malnutrition: contributes to rebuilding lean body mass. - Inherited metabolic disorders: supplies specific amino acids that may be deficient. - Critical illness or trauma: supports heightened protein turnover.

Adverse reactions to amino‑acid mixtures are generally uncommon but may occur.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Diarrhea: loose stools in sensitive individuals. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Hyperammonemia: elevated blood ammonia in patients with severe liver dysfunction. - Metabolic imbalance: abnormal electrolyte or acid‑base changes in vulnerable patients. - Severe gastrointestinal intolerance: persistent vomiting or severe diarrhea requiring medical attention.

When prescribing Olimel N9, clinicians should consider patient‑specific factors and follow standard safety practices. - Renal impairment: adjust dosage based on renal function and monitor nitrogen waste. - Hepatic dysfunction: assess risk of hyperammonemia and monitor liver enzymes. - Pregnancy and lactation: use only if clearly needed; weigh potential benefits against risks. - Pediatric use: dose must be calculated by weight and supervised by a specialist. - Concomitant nutrition therapy: avoid excessive total protein intake. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can interact with certain medicines, altering absorption or metabolic pathways.

Major Interactions (Avoid): - Levothyroxine: amino acids may reduce oral absorption; separate dosing by at least 4 hours. - Certain antibiotics (e.g., quinolones): chelation may diminish efficacy.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., valproate): may affect plasma amino‑acid levels. - Diuretics: increased renal loss of electrolytes may require monitoring. - Insulin therapy: enhanced protein intake can modify glucose control. - Iron supplements: concurrent intake may reduce amino‑acid absorption.